Skip to main content

Table 7 Univariate and multivariate analyses of prognostic factors for patients in the CTEPH PEA/BPA group

From: Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study

Variable

Univariate

Multivariate model 1

Multivariate model 2

Multivariate model 3

HR (95% CIv)

P

HR (95% CIv)

P

HR (95% CIv)

P

HR (95% CIv)

P

Age (years)

1.04 (0.991–1.085)

0.120

1.05 (1.001–1.097)

0.044

1.04 (0.991–1.087)

0.120

1.06 (0.999–1.139)

0.053

RAP (mmHg)

1.05 (0.929–1.158)

0.432

1.10 (0.967–1.261)

0.209

    

mPAP (mmHg)

1.03 (0.987–1.083)

0.153

      

CI (L/min/m2)

0.75 (0.334–1.560)

0.455

0.70 (0.272–1.587)

0.413

    

PVR (W.U)

1.08 (0.958–1.198)

0.209

      

PaO2 (mmHg)

1.00 (0.954–1.054)

0.873

      

PvO2 (mmHg)

1.05 (0.928–1.197)

0.419

1.15 (0.989–1.352)

0.069

  

1.02 (0.831–1.267)

0.851

PvO2 < 35 mmHg

1.54 (0.507–4.659)

0.430

  

1.22 (0.368–4.039)

0.742

  

RAP ≥ 8 mmHg

1.38 (0.447–4.229)

0.589

  

1.51 (0.438–5.215)

0.523

  

CI < 2.5 L/min/m2

1.26 (0.515–3.064)

0.616

  

1.07 (0.389–2.923)

0.901

  

SvO2 (mmHg)

0.99 (0.925–1.058)

0.730

      

A-aDO2 (mmHg)

0.97 (0.932–1.018)

0.241

      

BNP (pg/mL)

1.00 (0.998–1.002)

0.603

      

6MWD (m)

0.99 (0.988–0.999)

0.030

    

0.99 (0.988–1.001)

0.098

FVC, %pred. (%)

0.96 (0.957–1.006)

0.123

      

DLCO, %pred. (%)

0.98 (0.952–0.998)

0.033

    

0.98 (0.951–1.014)

0.279

WHO functional class I + II (vs. III + IV)

0.31 (0.070–1.332)

0.067

      
  1. Statistically significant, P < 0.05, are shown in bold
  2. A-aDO2 alveolar-arterial oxygen gradient, BNP brain natriuretic peptide, BPA balloon pulmonary angioplasty, CI cardiac index, CIv confidence interval, CTEPH chronic thromboembolic pulmonary hypertension, DLCO, %pred. percent predicted carbon monoxide diffusing capacity, FVC, %pred. percent predicted forced vital capacity, HR hazard ratio, mPAP mean pulmonary arterial pressure, PaO2 arterial oxygen tension, PEA pulmonary endarterectomy, PvO2 mixed venous oxygen tension, PVR pulmonary vascular resistance, RAP right arterial pressure, SvO2 mixed venous oxygen saturation, WHO World Health Organization, W.U Wood units, 6MWD 6-min walk distance
  3. Model 1: Multivariate analysis by ESC/ERS risk stratification and age
  4. Model 2: Multivariate analysis by ESC/ERS and French risk stratification in yellow and red zone, and age
  5. Model 3: Multivariate analysis adding age and PvO2 to variables that were significant in univariate analysis